Jose Portilla-Arias

Nanomedicine Research Center, Cedars-Sinai Medical Center

Affiliated withCedars-Sinai Medical Center

Research Area

Biography

Jose Portilla-Arias has not added Biography.
If you are Jose Portilla-Arias and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 23	2014

Other Publications

Article	Year
Nanostructurated complexes of poly(beta,L-malate) and cationic surfactants: synthesis, characterization and structural aspects. Biomacromolecules\| PubMed ID: 16398511	2006
Thermal decomposition of fungal poly(beta,L-malic acid) and Poly(beta,L-malate)s. Biomacromolecules\| PubMed ID: 17096562	2006
Ionic complexes of biosynthetic poly(malic acid) and poly(glutamic acid) as prospective drug-delivery systems. Macromolecular bioscience\| PubMed ID: 17599336	2007
Synthesis, degradability, and drug releasing properties of methyl esters of fungal poly(beta,L-malic acid). Macromolecular bioscience\| PubMed ID: 18322913	2008
Biodegradable nanoparticles of partially methylated fungal poly(beta-L-malic acid) as a novel protein delivery carrier. Macromolecular bioscience\| PubMed ID: 18350538	2008
Nanoparticles made of microbial poly(gamma-glutamate)s for encapsulation and delivery of drugs and proteins. Journal of biomaterials science. Polymer edition\| PubMed ID: 19454169	2009
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? NeuroImage\| PubMed ID: 20149882	2011
Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid). Pharmaceutical research\| PubMed ID: 20387095	2010
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected]. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 20921419	2010
Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity. Cancer research\| PubMed ID: 21303974	2011
The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery. Biomaterials\| PubMed ID: 21514661	2011
Poly(methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs. Macromolecular bioscience\| PubMed ID: 21793213	2011
Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer. PloS one\| PubMed ID: 22355336	2012
Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug Delivery. Journal of nanotechnology\| PubMed ID: 23024655	2010
Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers. Biomaterials\| PubMed ID: 23063368	2013
Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid). International journal of molecular sciences\| PubMed ID: 23109877	2012
Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 23770212	2013
Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment. Journal of drug targeting\| PubMed ID: 24032759	2013
Nanoparticles of Esterified Polymalic Acid for Controlled Anticancer Drug Release. Macromolecular bioscience\| PubMed ID: 24902676	2014